Have you got any experience? cefixime & azithromycin tablets use in hindi Now, moving to our balance sheet and cash flow metrics. Our balance sheet remained strong with cash and short investments at quarter end of $5.8 billion, up $514 million sequentially. Our operating cash flows remained strong as well and were $637 million, up 46% year-over-year. Our total cash spending on CapEx was $94 million and free cash flow was $543 million in Q3, up 50% year-over-year. Our cash flows this quarter reflected our robust operating performance with strong collections activities and lower expenses.